NEOLEUKIN THERAPEUTICS INC (NLTX) Stock Analyst Earnings Estimates
NASDAQ:NLTX - Nasdaq - US64049K2033 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 25M | -100.00% | 28.152M | 190.03M 575.01% | 481.85M 153.57% | 848.13M 76.02% | ||||||||||
| EBITDA YoY % growth | N/A -54.74% | N/A -33.79% | N/A | N/A | -39.28M -69.17% | -61.924M -45.67% | N/A 3.12% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -37.65M -76.43% | -51.12M -35.78% | -32.62M 36.19% | -84.66M 25.08% | -42.491M -70.05% | -63.373M -46.05% | -57.256M 2.64% | -32.761M 44.57% | -36.822M -12.40% | -36.38M 1.20% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | N/A | N/A | -130.48% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -1.96 -13.29% | -2.14 -9.18% | -1.35 36.92% | -13.46 44.44% | -3.65 -8.00% | -5.73 -171.13% | -5.02 -136.78% | -0.33 93.72% | -0.17 46.87% | -0.64 -268.65% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 23 | |
|---|---|
| EPS Q2Q % growth | -0.03 97.45% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -2.142M 84.97% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.41 65.83% | -0.03 | -0.38 | -1,239.87% |
| Q2 2023 Q2Q % growth | 97.09% | -0.04 | % | |
| Q1 2023 Q2Q % growth | -1.28 8.57% | -0.64 | -0.64 | -100.78% |
| Q4 2022 Q2Q % growth | -1.20 12.80% | -0.97 | -0.23 | -23.84% |
| Q3 2022 Q2Q % growth | -1.20 -328.57% | -1.55 | 0.35 | 22.67% |
| Q2 2022 Q2Q % growth | -1.40 -418.52% | -1.53 | 0.13 | 8.50% |
| Q1 2022 Q2Q % growth | -1.40 -418.52% | -1.51 | 0.11 | 7.47% |
| Q4 2021 Q2Q % growth | -1.38 -473.40% | -1.51 | 0.13 | 8.75% |
| Q3 2021 Q2Q % growth | -0.28 -47.37% | -0.28 | 0.00 | 1.37% |
| Q2 2021 Q2Q % growth | -0.27 -35.00% | -0.27 | 0.00 | -1.03% |
| Q1 2021 Q2Q % growth | -0.27 -50.00% | -0.23 | -0.04 | -16.10% |
| Q4 2020 Q2Q % growth | -0.24 -9.09% | -0.26 | 0.02 | 6.51% |
| Q3 2020 Q2Q % growth | -0.19 56.82% | -0.22 | 0.03 | 15.33% |
| Q2 2020 Q2Q % growth | -0.20 | -0.21 | 0.01 | 6.63% |
| Q1 2020 Q2Q % growth | -0.18 -100.00% | -0.24 | 0.06 | 25.22% |
| Q4 2019 Q2Q % growth | -0.22 | -0.38 | 0.16 | 41.71% |
| Q3 2019 Q2Q % growth | -0.44 | -0.04 | -0.40 | -978.43% |
| Q2 2019 Q2Q % growth | 0.00 | -0.05 | 0.05 | 100.00% |
| Q1 2019 Q2Q % growth | -0.09 | -0.23 | 0.14 | 61.64% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |